Design, synthesis and SAR of phenylamino-substituted 5,11-dihydro-dibenzo[a,d]cyclohepten-10-ones and 11H-dibenzo[b,f]oxepin-10-ones as p38 MAP kinase inhibitors

被引：24

作者：

Dorn, Angelika ^{[1
]}

Schattel, Verena ^{[1
]}

Laufer, Stefan ^{[1
]}

机构：

[1] Univ Tubingen, Inst Pharm, Dept Pharmaceut & Med Chem, D-72076 Tubingen, Germany

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2010年 / 20卷 / 10期

关键词：

Kinase inhibitors; Linear binders; DERIVATIVES; PROTEIN; ARTHRITIS; BINDING; ACIDS;

D O I：

10.1016/j.bmcl.2010.03.107

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The p38 MAP kinase is a key enzyme in inflammatory diseases as it is involved in the biosynthesis of proinflammatory cytokines such as TNF-alpha and IL-1 beta. Small molecule p38 inhibitors suppress the production of these cytokines and therefore p38 is a promising drug target for novel anti-inflammatory therapeutics. In this study, we report the design, synthesis, and SAR of novel N-substituted 11H-dibenzo[b,f]oxepin-10-ones and 5,11-dihydro-dibenzo[a,d]cyclohepten-10-ones as p38 inhibitors. (C) 2010 Elsevier Ltd. All rights reserved.

引用

页码：3074 / 3077

页数：4

共 17 条

[1] [Anonymous], [No title captured]
[2] Small-molecule inhibitors binding to protein kinases. Part I: exceptions from the traditional pharmacophore approach of type I inhibition
Backes, A. C.
Zech, B.
Felber, B.
Klebl, B.
Mueller, G.
[J]. EXPERT OPINION ON DRUG DISCOVERY, 2008, 3 (12) : 1409 - 1425
[3] Palladium catalyzed ligand-free Suzuki cross-coupling reactions of benzylic halides with aryl boronic acids under mild conditions
Bandgar, BP
Bettigeri, SV
Phopase, J
[J]. TETRAHEDRON LETTERS, 2004, 45 (37) : 6959 - 6962
[4] Palladium catalyzed cross-coupling between phenyl- or naphthylboronic acids and benzylic bromides
Chowdhury, S
Georghiou, PE
[J]. TETRAHEDRON LETTERS, 1999, 40 (43) : 7599 - 7603
[5] Rheumatoid arthritis
Feldmann, M
Brennan, FM
Maini, RN
[J]. CELL, 1996, 85 (03) : 307 - 310
[6] Pathogenesis of arthritis: recent research progress
Feldmann, M
[J]. NATURE IMMUNOLOGY, 2001, 2 (09) : 771 - 773
[7] p38 map kinases: Key signalling molecules as therapeutic targets for inflammatory diseases
Kumar, S
Boehm, J
Lee, JC
[J]. NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (09) : 717 - 726
[8] An immunosorbent, nonradioactive p38 MAP kinase assay comparable to standard radioactive liquid-phase assays
Laufer, S
Thuma, S
Peifer, C
Greim, C
Herweh, Y
Albrecht, A
Dehner, F
[J]. ANALYTICAL BIOCHEMISTRY, 2005, 344 (01) : 135 - 137
[9] Design, synthesis, and biological evaluation of phenylamino-substituted 6,11-dihydro-dibenzo[b,e]oxepin-11-ones and dibenzo[a,d]cycloheptan-5-ones:: Novel p38 MAP kinase inhibitors
Laufer, Stefan A.
Ahrens, Gabriele M.
Karcher, Solveigh C.
Hering, Joerg S.
Niess, Raimund
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (26) : 7912 - 7915
[10] A PROTEIN-KINASE INVOLVED IN THE REGULATION OF INFLAMMATORY CYTOKINE BIOSYNTHESIS
LEE, JC
LAYDON, JT
MCDONNELL, PC
GALLAGHER, TF
KUMAR, S
GREEN, D
MCNULTY, D
BLUMENTHAL, MJ
HEYS, JR
LANDVATTER, SW
STRICKLER, JE
MCLAUGHLIN, MM
SIEMENS, IR
FISHER, SM
LIVI, GP
WHITE, JR
ADAMS, JL
YOUNG, PR
[J]. NATURE, 1994, 372 (6508) : 739 - 746

← 1 2 →